Skip to main content
OpenTrials
Completed

NCT Number: NCT05556915

Benefit of Ultrasound Guidance in Arteriovenous Fistula (AVF) Cannulation in Pediatric Hemodialysis

The arteriovenous fistula (AVF) is the reference hemodialysis vascular access for both adult and pediatric patients. The cannulation quality is decisive for the quality of the dialysis. Difficult AVF cannulations are more frequent in pediatrics than in adults. Recent studies in adults have shown that ultrasound-guided AVF cannulation improves the cannulation quality and therefore the quality of dialysis. This study aims to prove that ultrasound-guided AVF cannulation in children will improve the quality of dialysis overall.

Completed

Looking for future studies?

Notify Me

Key information

Age range

2 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Uh Montpellier

Montpellier, 34295, France

About this study

The European and American recommandations emphasize that the arteriovenous fistula (AVF) is the first choice vascular access in hemodialysis for both adult and pediatric patients. Indeed, infections and thrombotic complications are lower with an AVF than with a central venous catheter. In addition, the efficiency of dialysis is better in patients with AVF in both pediatric and adult patients.

The pediatric population has its own characteristics. On the one hand, the size of the vessels, in particular in patients weighing less than 20 kilos, complicates the creation of the AVF. On the other hand, the time for AVF maturation in children (corresponding to the time required between the creation of the AVF and its use) is much higher than that of the adult population. These specific anatomical characteristics partly explain the more frequent AVF cannulation difficulties in pediatric patients.

Inadequate dialysis is considered to be a session in which the therapy goals were not achieved. This rate of inadequate dialysis is estimated at 8-10% in children due to vascular access problem, whereas this rate is only 1 to 5% in adults. There is also an increase in side effects related to these pediatric AVF cannulation difficulties (trauma, hematoma, edema following diffusion, etc.) responsible for inadequate dialysis and, in the long term, AVF dysfunction (stenosis, thrombosis).

The preservation of the vascular access by means of new cannulation techniques aimed at limiting trauma is therefore a primary objective in pediatric hemodialysis. The introduction of new cannulation methods as well as the training of nurses/childcare workers in the various puncture techniques would thus make it possible to improve the quality of dialysis sessions, the lifespan of AVFs, to increase the number of puncture sites and reduce the number of punctures per session and the occurrence of complications.

Recently, the ultrasound-guided AVF cannulation technique has shown promising results in adults with regard to the prevention of vascular access complications, the feeling of pain and the obtaining of adequate dialysis.

A recent review points to the need to confirm the benefit of ultrasound-guided cannulation through randomized studies, the current data being promising but needing to be confirmed. To date, no data concerning the benefit of ultrasound-guided cannulation in pediatrics is available in the literature. Our project will therefore be the first research to compare 2 AVF cannulation methods in pediatric hemodialysis. The hypothesis adopted is that the AVF cannulation using ultrasound guidance in children undergoing dialysis will allow an overall improvement of dialysis quality, a reduction of complication occurrence and an improvement of patient comfort.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pediatric patients ˂ 18 years of age at enrollment
  • Patients with end-stage renal disease undergoing hemodialysis therapy
  • Patients carrying an arteriovenous fistula created more than 6 weeks before enrollment
  • Prior agreement of the patient and their legal representative by signing the parent's informed consent form
  • Patients affiliated to social security system

Exclusion criteria

  • Non-matured arteriovenous fistula according to the referring pediatrician
  • Patients undergoing dialysis at least partly through a central venous catheter
  • Estimated duration of dialysis less than 1 month in the investigation center
  • Participation in other intervention research

Treatment and study plan

Ultrasound-guided AVF cannulation method

Other

For ultrasound-guided cannulation, the same ultrasound device will be used for all patients (TE5-POC ultrasound MINDRAY® system). The ultrasound device will identify the AVF aspect , the location including the depth (distance from the skin surface) , the vessel diameter and guide the cannulation in real-time. The device will be disinfected between uses and covered with a transparent adhesive film to avoid any direct contact with the patient. Sterile gel will be used for the cannulation.

Conventional AVF cannulation method

Other

The AVF cannulation is carried out by palpation. This technique consists of manually evaluating the position, direction and depth of the fistula in order to determine the puncture site where the 2-dialysis catheters will be inserted. After local asepsis, the AVF is therefore needled at 2 points 5 cm apart.

Primary outcomes

  1. Compare the rate of inadequate dialysis after ultrasound-guided AVF cannulation vs. conventional cannulation in pediatric patients (<18 years) with end-stage renal disease undergoing hemodialysis therapy.

    Time frame: 12 months

    Inadequate dialysis is defined by the presence of one of the following parameters:

    • Blood flow rate (BFR expressed in ml/min corresponding to the volume of blood in milliliters that flows per minute) less than 80% of adequate blood flow corresponding to a flow ≥ 7 ml per kilograms of weight with a maximum of 300 ml/min
    • Requirement of single-needle dialysis after 3 cannulation failures
    • Early discontinuation of hemodialysis
    • Loss of dialysis circuit during the session
    • Out of range arterial or venous pressure during dialysis requiring a drop in blood flow rate
    • Purification coefficient defined by Kt/V <1.2: K represents the dialyzer clearance of urea (expressed in milliliters/ min and corresponds to the volume of blood in ml cleared of urea per minute ) // t (in minutes) represents the dialysis time duration // V (in milliliters) represents the volume of distribution of urea, and equals the patient's total body water

Secondary outcomes

  1. Number of cannulations required for the insertion of the 2 dialysis catheters

    Time frame: During procedure

    Compare the number of cannulations required for the insertion of the 2 dialysis catheters in conventional method vs ultrasound-guided method

  2. The time required for the insertion of the 2 catheters

    Time frame: During procedure

    Compare the time required for the insertion of the 2 catheters in conventional method vs ultrasound-guided method

  3. The occurrence of cannulation complications

    Time frame: During procedure

    Compare the occurrence of cannulation complications (hematoma, diffusion, aneurysm, etc.) in conventional method vs ultrasound-guided method

  4. The occurrence of dialysis incidents caused by catheters dysfunction

    Time frame: During procedure

    Compare the occurrence of dialysis incidents caused by catheters dysfunction (decrease in dialysis flow, single-puncture dialysis, shortening of dialysis time, loss of circuit) in conventional method vs ultrasound-guided method

  5. Patient satisfaction

    Time frame: 30 days, 90 days, 180 days and 12 months after enrollment

    Compare the patient satisfaction in conventional method vs ultrasound-guided method using a satisfaction questionnaire

  6. Patient comfort

    Time frame: During the procedure

    Compare the patient comfort in conventional method vs ultrasound-guided method. The visual analogue scale (VAS) will be used by patients > 5 years of age. The VAS measures from 0 to 10 the intensity of pain. The higher the score the less comfortable the procedure

  7. Patient comfort

    Time frame: During the procedure

    Compare the patient comfort in conventional method vs ultrasound-guided method. The neonatal pain and discomfort scale (EDIN Échelle Douleur Inconfort Nouveau-Né ) will be used by patients ≤ 5 years of age.

    The EDIN scale uses five behavioural indicators of pain: facial activity, body movements, quality of sleep, quality of contact with nurses, and consolability.

    The scale measures friom 0 to 15 the intensity of pain. The higher the score the less comfortable the procedure

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Registry information

Official study title

Intérêt De L'échoguidage Dans Les Ponctions De Fistule Artério-veineuse En Hémodialyse Pédiatrique

Acronym: PafusGuC

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Sep 27, 2022
Registry last updated
Jan 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.